X. Edward Zhou

X. Edward Zhou

Auto-generated profile, based on publicly available information

X. Edward Zhou

Department of Structural Biology, Van Andel Institute, Grand Rapids, MI 49503, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2019 in Science
Verified
Journal Article
Closed access
PDF file
LZLi-Hua Zhao
Li-Hua Zhao
SMShanshan Ma
Shanshan Ma
ISIeva Sutkeviciute
Ieva Sutkeviciute
DSDan-Dan Shen
Dan-Dan Shen
XZX. Edward Zhou
X. Edward Zhou
YZYan Zhou
Yan Zhou
Bone-cell regulation, fleshed out: One of many medically relevant G protein–coupled receptors, parathyroid hormone receptor-1 (PTH1R) functions in the control of calcium homeostasis and bone physiology. Zhao et al. used cryo–election microscopy to observe the structure of PTH1R in a complex with a modified form of parathyroid hormone and stimulatory G protein. The structural model helps explain how parathyroid hormone interacts with its receptor and the molecular basis for receptor activation. Science , this issue p. 148

23 July 2021 in Science
Verified
Journal Article
Closed access
PDF file
YYYan Yan
Yan Yan
SMSomnath Mukherjee
Somnath Mukherjee
DHDr. Kaleeckal Harikumar
Dr. Kaleeckal Harikumar
TSTimothy S. Strutzenberg
Timothy S. Strutzenberg
XZX. Edward Zhou
X. Edward Zhou
KMKarsten Melcher
Karsten Melcher
How to catch a dynamic state: AMP-activated protein kinase (AMPK) is a key sensor of energy status in eukaryotes. Its dynamic structure is regulated by allosteric factors including phosphorylation and binding of nucleotides and metabolites. Yan et al. developed conformation-specific antibodies that trap AMPK in a fully inactive state that has experienced a large, domain-level rotation. Biophysical experiments in cells and in vitro are consistent with the structural work and support a model in which the activation loop is fully exposed in the completely inactive, dephosphorylated state. These structures inform our understanding of the complex allosteric behavior in this crucial metabolic regulator. Science , abe7565, this issue p. 413

12 March 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YZYuxin Zhou
Yuxin Zhou
XZX Edward Zhou
X Edward Zhou
YGYuanping Gong
Yuanping Gong
YZYuanye Zhu
Yuanye Zhu
XCXiaoman Cao
Xiaoman Cao
FZFeng Zhang
Feng Zhang
Fusarium is a genus of filamentous fungi that includes species that cause devastating diseases in major staple crops, such as wheat, maize, rice, and barley, resulting in severe yield losses and mycotoxin contamination of infected grains. Phenamacril is a novel fungicide that is considered environmentally benign due to its exceptional specificity; it inhibits the ATPase activity of the sole class I myosin of only a subset of Fusarium species including the major plant pathogens F. graminearum, F. asiaticum and F. fujikuroi. To understand the underlying mechanisms of inhibition, species specificity, and resistance mutations, we have determined the crystal structure of phenamacril-bound F. graminearum myosin I. Phenamacril binds in the actin-binding cleft in a new allosteric pocket that contains the central residue of the regulatory Switch 2 loop and that is collapsed in the structure of a myosin with closed actin-binding cleft, suggesting that pocket occupancy blocks cleft closure. We have further identified a single, transferable phenamacril-binding residue found exclusively in phenamacril-sensitive myosins to confer phenamacril selectivity. Phenamacril is a recently identified myosin I inhibitor that is a potent and highly species-specific and myosin subtype-selective fungicide. We report the high-resolution structure of the phenamacril-bound myosin I motor domain of the major crop pathogen Fusarium graminearum, providing insight into the molecular mechanism of phenamacril action and resistance. These results are of broad significance for understanding the mode of actions of myosin-based fungicides and for designing novel myosin I inhibitors for crop protection and for treatment of human myosin dysfunction diseases.

13 June 2025 in bioRxiv
Verified
Preprint
Open access
YYYan Yan
Yan Yan
XZX. Edward Zhou
X. Edward Zhou
STStacey L Thomas
Stacey L Thomas
MLMinmin Liu
Minmin Liu
GLGanqiang Lai
Ganqiang Lai
TXTing-Hai Xu
Ting-Hai Xu
De novo DNA methylation is a fundamental epigenetic process essential for early development. It is mediated by DNA methyltransferase DNMT3A and DNMT3B, in cooperation with catalytically inactive DNMT3L. Abnormal DNA methylation contributes to genomic instability and oncogenesis, yet the mechanisms governing its establishment and regulation remain unclear. Here, we present high-resolution cryo-EM structures of the nucleosome-bound full-length DNMT3A2-3L and its oligomeric assemblies in the nucleosome-free state. Strikingly, DNMT3L C-terminal “Switching Helix” displayed a distinct conformation with a 180° rotational difference compared to its DNMT3B3 counterpart in the presence of nucleosome, preventing direct interactions with the nucleosome acidic patch. Instead, DNMT3L ADD domain promotes nucleosome binding, while DNMT3A PWWP domain inhibits it, indicating multi-layer regulation. Additionally, the novel oligomeric arrangement of DNMT3A2-3L in nucleosome-free states highlights its dynamic assembly and potential allosteric regulation. Furthermore, we identified the critical role of DNMT3L as a sensor of histone modifications, guiding the complex’s chromatin interaction. These findings uncover a previously unknown mechanism by which DNMT3A-3L mediates de novo DNA methylation on chromatin through complex reorganization, histone tail sensing, dynamic DNA search, and nucleosome engagement, providing key insights into epigenetic regulation.